(Q36350919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1

Aldo Clerico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

Michele Emdin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Fabio A Recchia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology Heart and Circulatory Physiology

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

H17-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms.

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Natriuretic peptide receptor-C signaling and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Natriuretic peptide gene expression after beta-adrenergic stimulation in adult mouse cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Natriuretic peptides and myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

NT-proBNP and BNP: biomarkers for heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Raised plasma levels of atrial natriuretic peptides in Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain natriuretic peptide: a potential marker for mortality in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Mechanisms of renal hyporesponsiveness to ANP in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

BNP and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Can natriuretic peptides be used for the diagnosis of diastolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Vasopeptidase inhibitors in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

B-type natriuretic peptide in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Negative regulators of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Natriuretic peptides in unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Neurohormonal determinants of peak oxygen uptake in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Stimulation of brain natriuretic peptide release from the heart by thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Estrogen, natriuretic peptides and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Stress-activated cytokines and the heart: from adaptation to maladaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Determinants of natriuretic peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Obesity and suppressed B-type natriuretic peptide levels in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: comparison of electrocardiography, chest radiography and echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Biology of natriuretic peptides and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

B-type natriuretic peptide in heart transplantation: an important marker of allograft performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Plasma brain natriuretic peptide concentration: impact of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

BNP in hormone-guided treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

NT-proBNP in heart failure: therapy decisions and monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Cardiac hormones as diagnostic tools in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Ontogenic expression of natriuretic peptide mRNAs in postnatal rat brain: implications for development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Urinary excretion of urodilatin in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Characterization of molecular forms of probrain natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

p38 Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Nesiritide — Not Verified

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Increased Plasma Concentration of Natriuretic Peptides by Selective β1-Blocker Bisoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Nitrergic modulation of vasopressin, oxytocin and atrial natriuretic peptide secretion in response to sodium intake and hypertonic blood volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Natriuretic peptides and acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Expression and differential regulation of natriuretic peptides in mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Fibrosis rather than blood pressure determines cardiac BNP expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

ANP inhibits TNF-alpha-induced endothelial MCP-1 expression--involvement of p38 MAPK and MKP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00684.2005

10.1152/AJPHEART.00684.2005

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16373590%20AND%20SRC:MED&resulttype=core&format=json

release_doumysaxwva2vfnonfhrqiwnzy

14 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/doumysaxwva2vfnonfhrqiwnzy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference